25.03.2013 Views

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

Hyperbaric Oxygen Therapy - Hyperbaric Chamber Information ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Thirty-seven subjects (comparison group) were allocated to receive 450 mg of<br />

prednisone in 10-mg tablets over 8 days in the following manner: days 1-4, four tablets<br />

twice a day; day 5, three tablets three times a day; day 6, two tablets twice a day; day 7,<br />

one tablet twice a day; and day 8, one tablet. This group was also exposed to a sham<br />

HBOT procedure by placement in a monoplace chamber infused with seven percent<br />

oxygen at 2.8 ATA for one hour, twice a day, five days a week for a maximum of 30<br />

sessions.<br />

The remaining 42 subjects (intervention group) were given placebo tablets and were<br />

instructed to take them in the manner previously described. This group was exposed to<br />

100% oxygen in the same pressures, duration, and frequency as the comparison group.<br />

The authors report (Table 56) that total recovery from paralysis occurred in 40 of 42<br />

(95.2%; 95% CI = 88.8, 100%) patients from the intervention group compared to 28 of<br />

37 (75.7%; 95% CI = 61.8, 89.5%) patients in the comparison group. The average<br />

duration of symptoms was also shorter in the intervention group, as was the proportion<br />

found to be positive on the nerve excitability test. These results were statistically<br />

significant at the 5 percent level.<br />

Table 56 Major outcomes following treatment for facial paralysis in intervention and comparison<br />

groups (Racic et al). 92<br />

Outcome<br />

Intervention<br />

Group (n = 42)<br />

Comparison<br />

Group (n = 37)<br />

Complete recovery (n) 40 28 0.0122<br />

Average duration of symptoms (days) 22 34.4 < 0.001*<br />

Number positive on nerve excitability test (n)<br />

During course of treatment<br />

At nine months<br />

* This value is reported in the text. No standard deviations were given to allow an independent calculation of this probability.<br />

<strong>Hyperbaric</strong> oxygen therapy 57<br />

5<br />

2<br />

9<br />

9<br />

p<br />

0.1492<br />

0.0122<br />

Summary<br />

This report provided some evidence of the benefit of exposure to HBO for subjects with<br />

moderate to severe forms of facial paralysis of less than one week duration. Replication<br />

of this study to other settings and an examination of other outcomes are required to<br />

come to firm and generalisable conclusions.<br />

Sudden deafness and acoustic trauma<br />

Four studies were identified that meet inclusion criteria for this indication. A brief<br />

description of each study is given in Table 57.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!